SCHEMBL1490785

SCHEMBL1490785

CCOCC(=O)Nc1cnc2cc(Br)cnc2c1NN(C(=O)OC(C)(C)C)C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 14/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 4/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPT P10636 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RAB9A P51151 5/20 0.34
KMT2A Q03164 3/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
NPC1 O15118 4/20 0.34
MAPK1 P28482 2/20 0.34
HTT P42858 2/20 0.34
TP53 P04637 2/20 0.33
POLB P06746 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1490847 0.99 ALDH1A1 (0.36) ALDH1A1HPGDKDM4EHSD17B10MAPT
Hydrochloric Acid SCHEMBL5824061 0.89 ALDH1A1 (0.36) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL1490782 0.80 CYP1A2 (0.36) ALDH1A1HPGDKDM4EHSD17B10MAPT
Hydrochloric Acid SCHEMBL1490846 0.80 CYP1A2 (0.36) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL1491010 0.79 AAK1 (0.34)
Hydrochloric Acid SCHEMBL1490912 0.79 ALDH1A1 (0.38) ALDH1A1HPGDKDM4EHSD17B10MAPT
Hydrochloric Acid SCHEMBL5824055 0.76 ALDH1A1 (0.36) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL1490946 0.76 MET (0.35) MAPTCYP1A2CYP2C19SMN1; SMN2
Hydrochloric Acid SCHEMBL1490938 0.72 ALDH1A1 (0.35) ALDH1A1HPGDKDM4EHSD17B10MAPT
SCHEMBL3861813 0.69 ALDH1A1 (0.42) ALDH1A1HPGDKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897609-B2 Aryl substituted imidazonaphthyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-03-01 US disclosed
US-20070219228-A1 Aryl substituted imidazonaphthyridines 3M INNOVATIVE PROPERTIES COMPANY 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219228-A1 Aryl substituted imidazonaphthyridines IL2, IRF3, EIF2AK2 ALDH1A1 1178/4885HPGD 449/4885KDM4E 3178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.